New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Acumen Pharmaceuticals, Inc. (ABOS) vs BioStem Technologies, Inc. (BSEM)
- Acumen Pharmaceuticals, Inc. ABOS 0.19 0.00%
- BioStem Technologies, Inc. BSEM 0.64 −9.86%
Acumen Pharmaceuticals, Inc. and BioStem Technologies, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and BioStem Technologies, Inc. are of similar size ($14.0M and $13.6M). BioStem Technologies, Inc. has the higher net margin (−121.0% vs −510.1%) and the lower return on invested capital (−7.07% vs 0.00%). Across the 11 metrics below, Acumen Pharmaceuticals, Inc. leads on 6 and BioStem Technologies, Inc. on 5.
Valuation
Profitability
| Metric | ABOS | BSEM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 79.83% | 70.18% |
| Operating margin | (550.97%) | (6.18%) | 0.00% |
| Net margin | (510.10%) | (121.02%) | 0.00% |
| Free cash flow margin | (518.80%) | — | 0.00% |
| Return on equity | (162.72%) | — | (51.58%) |
| Return on assets | (91.28%) | — | (45.91%) |
| Return on invested capital | 0.00% | (7.07%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack